Pages that link to "Q37989867"
Jump to navigation
Jump to search
The following pages link to Interleukin-7 and immune reconstitution in cancer patients: a new paradigm for dramatically increasing overall survival (Q37989867):
Displaying 23 items.
- Establishment of IL-7 Expression Reporter Human Cell Lines, and Their Feasibility for High-Throughput Screening of IL-7-Upregulating Chemicals (Q28553886) (← links)
- Emerging therapeutic targets of sepsis-associated acute kidney injury (Q30300333) (← links)
- IL-18 synergizes with IL-7 to drive slow proliferation of naive CD8 T cells by costimulating self-peptide-mediated TCR signals (Q34289372) (← links)
- Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients. (Q36057482) (← links)
- Immunomodulatory and anticancer potential of Gan cao (Glycyrrhiza uralensis Fisch.) polysaccharides by CT-26 colon carcinoma cell growth inhibition and cytokine IL-7 upregulation in vitro (Q36073299) (← links)
- Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation (Q36462428) (← links)
- Efforts of the human immune system to maintain the peripheral CD8+ T cell compartment after childhood thymectomy (Q36530581) (← links)
- A rapidly progressing lymphocyte exhaustion after severe sepsis (Q36633849) (← links)
- Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach (Q37233354) (← links)
- The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer? (Q37563023) (← links)
- The new normal: immunomodulatory agents against sepsis immune suppression (Q37686624) (← links)
- Chemoimmunotherapy: reengineering tumor immunity (Q38079749) (← links)
- ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients. (Q38413705) (← links)
- Role of cellular events in the pathophysiology of sepsis (Q38890353) (← links)
- Dying to protect: cell death and the control of T-cell homeostasis. (Q39277476) (← links)
- Interleukin-7, a new immunoadjuvant for the treatment of septic shock (Q45241698) (← links)
- T helper type 2-polarized invariant natural killer T cells reduce disease severity in acute intra-abdominal sepsis. (Q51071957) (← links)
- The perioperative dynamics of IL-7 following robot-assisted and open colorectal surgery. (Q55381850) (← links)
- Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines? (Q64107755) (← links)
- Recent successes of cancer immunotherapy: a new dimension in personalized medicine? (Q83476749) (← links)
- Immune therapy in sepsis: Are we ready to try again? (Q90261730) (← links)
- How the ageing microenvironment influences tumour progression (Q91973843) (← links)
- Local and Systemic IL-7 Concentration in Gastrointestinal-Tract Cancers (Q92661775) (← links)